BALYASNY ASSET MANAGEMENT L.P. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,223,427
-93.1%
146,343
-79.6%
0.00%
-94.9%
Q2 2023$17,809,386
+233.3%
716,964
+101.8%
0.04%
+200.0%
Q1 2023$5,342,930
+8517.6%
355,248
+3283.6%
0.01%
Q3 2022$62,000
-98.9%
10,499
-98.2%
0.00%
-100.0%
Q1 2022$5,531,000
+9.4%
581,587
+118.5%
0.02%0.0%
Q4 2021$5,057,000
+1898.8%
266,176
+935.4%
0.02%
+466.7%
Q1 2020$253,000
-55.9%
25,707
-74.9%
0.00%0.0%
Q3 2018$574,000
-16.2%
102,571
+97.0%
0.00%0.0%
Q2 2018$685,00052,0600.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders